BRAF and melanoma: The study allowed to identify lncRNAs that cooperated in addition to v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutations to establish resistance to BRAF inhibitor in melanoma cells: these lncRNAs overexpressed in BRAFi-resistant cell lines have been determined to contribute to a gain-of-function phenotype [205, 206].